Mitri Zahi, Esmerian Maria O, Simaan Joseph A, Sabra Ramzi, Zgheib Nathalie K
Department of Pharmacology and Therapeutics, Faculty of Medicine, American University of Beirut, Lebanon.
J Med Liban. 2010 Apr-Jun;58(2):101-4.
Pharmacogenetics, the study of interindividual variations in DNA sequence related to drug response, aims at the optimization of treatment regimens based on each patient's unique genetic makeup. Currently, there is a trend towards moving away from the concept of "one drug fits all" to a rather more individualized and personalized medicine. The goal is to define the appropriate drug dose that maximizes efficacy and minimizes toxicity in each individual patient. An example of genotyping for CYP2C9 genetic polymorphisms in patients receiving oral anticoagulants is provided. In spite of its inherent challenges, we hope that pharmacogenetic research and clinical applications expand to improve healthcare outcomes in Lebanon and worldwide.
药物遗传学是对与药物反应相关的DNA序列个体间差异的研究,旨在根据每个患者独特的基因构成优化治疗方案。目前,有一种趋势是从“一种药物适用于所有人”的概念转向更加个体化和个性化的医学。目标是确定适当的药物剂量,以使每个患者的疗效最大化且毒性最小化。文中提供了一个在接受口服抗凝剂治疗的患者中对CYP2C9基因多态性进行基因分型的例子。尽管存在固有的挑战,但我们希望药物遗传学研究和临床应用能够扩大,以改善黎巴嫩乃至全球的医疗保健结果。